MedTrace Logo

Mother-Infant Psychoanalysis Project of Stockholm (MIPPS)- Follow-up at 4½ Years

NCT01087112 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2010-03-16

No results posted yet for this study

Summary

An RCT comparing mother-infant psychoanalytic treatment (MIP) with Child Health Centre care in cases of mother-infant relationship disturbances was performed on 80 cases in Stockholm 2005-2008. The infants were \< 18 months at interview #1. At 6 months follow-ups, significant effects were shown in favour of MIP on maternal sensitivity (EAS), depression (EPDS), and relationship qualities PIR-GAS). This study will evaluate effects at a child age of 4½ years; to evaluate the longterm effects of MIP and CHild Health Centre care, and to better validate results on children who now have reached an age where they can participate more actively in evaluations.

Conditions

  • Mother-child Relationship Disturbances

Interventions

BEHAVIORAL

Mother-Infant Psychoanalytic tmt

Psychoanalytic sessions with mother and infant, at a median of 23 sessions 2 times weekly.

BEHAVIORAL

Child Health Centre care

Nurse calls at Child Health Centres (CHC), with regular paediatric checkups. The nurse was encouraged to promote attachment and to detect postnatal depressions. Appointments with a psychiatrist or therapist or child psychiatric psychologist was initiated in 1/3 of the cases. This was registered at the end-point interview.

Sponsors & Collaborators

Principal Investigators

  • Björn Salomonsson, MD · Department of Women's and Children's Health, Child and Adolescent Psychiatry Unit, Karolinska Institutet

  • Majlis Winberg Salomonsson, M.Sci.Psych. · Department of Women's and Children's Health, Child and Adolescent Psychiatry Unit, Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
54 Months
Max Age
54 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2012-06-30
Completion
2013-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01087112 on ClinicalTrials.gov